Laddar...
Intrathecal administration of autologous mesenchymal stem cells in multiple system atrophy
OBJECTIVE: This phase I/II study sought to explore intrathecal administration of mesenchymal stem cells (MSCs) as therapeutic approach to multiple system atrophy (MSA). METHODS: Utilizing a dose-escalation design, we delivered between 10 and 200 million adipose-derived autologous MSCs intrathecally...
Sparad:
| I publikationen: | Neurology |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Lippincott Williams & Wilkins
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6659003/ https://ncbi.nlm.nih.gov/pubmed/31152011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000007720 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|